These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17704399)

  • 1. Predicting outcomes in prostate cancer: how many more nomograms do we need?
    Ross RW; Kantoff PW
    J Clin Oncol; 2007 Aug; 25(24):3563-4. PubMed ID: 17704399
    [No Abstract]   [Full Text] [Related]  

  • 2. A catalog of prostate cancer nomograms.
    Ross PL; Scardino PT; Kattan MW
    J Urol; 2001 May; 165(5):1562-8. PubMed ID: 11342918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer nomograms: an update.
    Chun FK; Karakiewicz PI; Briganti A; Gallina A; Kattan MW; Montorsi F; Huland H; Graefen M
    Eur Urol; 2006 Nov; 50(5):914-26; discussion 926. PubMed ID: 16935414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family physicians could help in predicting life expectancy without prostate cancer.
    Mohan R
    J Clin Oncol; 2008 Feb; 26(4):690-1; author reply 691-3. PubMed ID: 18235137
    [No Abstract]   [Full Text] [Related]  

  • 5. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    Giard RW
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2099-100; author reply 2100. PubMed ID: 18837188
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we need more nomograms for predicting outcomes in patients with prostate cancer?
    Kattan MW
    Nat Clin Pract Urol; 2008 Jul; 5(7):366-7. PubMed ID: 18506152
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting survival for men with clinically localized prostate cancer: what do we need in contemporary practice?
    Albertsen P
    Cancer; 2008 Jan; 112(1):1-3. PubMed ID: 18000802
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
    Shariat SF; Karakiewicz PI; Suardi N; Kattan MW
    Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information content of five nomograms for outcomes in prostate cancer.
    Bismar TA; Humphrey P; Vollmer RT
    Am J Clin Pathol; 2007 Nov; 128(5):803-7. PubMed ID: 17951203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life expectancy estimation by nomogram.
    Froehner M
    J Clin Oncol; 2008 Feb; 26(4):690; author reply 691-3. PubMed ID: 18235138
    [No Abstract]   [Full Text] [Related]  

  • 11. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.
    Shimizu F; Igarashi A; Fukuda T; Kawachi Y; Minowada S; Ohashi Y; Fujime M
    Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting life expectancy in prostate cancer patients.
    Jeldres C; Latouff JB; Saad F
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):166-9. PubMed ID: 19553817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques and predictive models to improve prostate cancer detection.
    Herman MP; Dorsey P; John M; Patel N; Leung R; Tewari A
    Cancer; 2009 Jul; 115(13 Suppl):3085-99. PubMed ID: 19544550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive models in diagnosing indolent cancer.
    Bangma CH; Roobol MJ; Steyerberg EW
    Cancer; 2009 Jul; 115(13 Suppl):3100-6. PubMed ID: 19544551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms for prostate cancer--is their use evidence-based?
    Stapleton AM; Pinnock CB
    Nat Clin Pract Urol; 2005 Oct; 2(10):462-3. PubMed ID: 16474602
    [No Abstract]   [Full Text] [Related]  

  • 18. Inventory of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
    Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should men over the age of 65 years receive PSA screening? Argument against.
    Albertsen PC
    Nat Clin Pract Urol; 2008 May; 5(5):232-3. PubMed ID: 18349860
    [No Abstract]   [Full Text] [Related]  

  • 20. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
    Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.